Abstract:Hypertension is linked to Alzheimer’s Disease (AD) risk, although the mechanisms remain unclear. The renin angiotensin system (RAS), critical for blood pressure homeostasis, is thought to contribute to AD pathology, and targeted RAS therapies are under current clinical investigation. To further evaluate the neurobiological mechanisms of RAS in AD, the current study leveraged two transgenic AD mouse models to compare the behavioral and cognitive deficits and the brain RAS in male and female mice. A triple‐transgenic mouse model of AD (3xTg‐AD), which exhibits both amyloid beta and tau pathology, was used for in‐house assays, while an RNA‐sequencing database using a novel mouse model on a genetically diverse background (AD‐BXD) (GEO accession number GSE119215) was used to compare expression levels of hippocampal RAS genes at 6 and 14 mos. Morris water maze (MWM) and Y‐maze alternation tests were performed at early (3‐4 mos) and middle (5‐6 mos) time points on 3xTg‐AD mice (n = 8/sex/age/genotype), followed by collection of plasma and whole brain. Compared to controls, beginning at 3.5 months, 3xTg‐AD male and female mice exhibited deficits in learning assessed by MWM escape latency (p<0.01). However, beginning at 6 months, only 3xTg‐AD females had deficits in memory assessed by Y‐maze alternation below 50% (i.e. chance) (p<0.05). Sex‐dependent deficits are consistent with variability in phenotype beginning at early time points. Next we assessed hippocampal RNA‐sequencing data from the AD‐BXD database. These data demonstrated a sex‐dependent increase in expression of counter‐regulatory RAS genes ACE (p<0.0001) and ACE2 (p<0.05) and decrease in MasR (p<0.01) when comparing 6 and 14 month females, as compared to males and wild‐type controls. There was no change in classical RAS gene expression, indicating that variation in expression of neuroprotective but not classical RAS genes may be more pronounced in aging female mice. Our results demonstrate sex and stage‐specific behavioral deficits in the 3xTg‐AD model, which may be linked to changes in hippocampal regulation of the counter‐regulatory arm of brain RAS. Additional studies are needed to further evaluate underlying mechanisms for the role of the neuroprotective arm of the brain RAS in AD and its biomarker and therapeutic targeting potential.

Towards developing a rhesus monkey model of early Alzheimer's disease focusing on women's health

Rhesus monkeys as a translational model for late‐onset Alzheimer's disease

A novel tau‐based rhesus monkey model of Alzheimer's pathogenesis

Aged rhesus monkeys: Cognitive performance categorizations and preclinical drug testing

Age-associated changes in amyloid-β and formaldehyde concentrations in cerebrospinal fluid of rhesus monkeys

Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease

Temporal progression of tau pathology and neuroinflammation in a rhesus monkey model of Alzheimer's disease

Neuronal and morphological bases of cognitive decline in aged rhesus monkeys

Pathological Markers of Alzheimer's Disease and Related Dementia in the Rhesus Macaque Amygdala

A nonhuman primate model with Alzheimer's disease-like pathology induced by hippocampal overexpression of human tau

Brains of rhesus monkeys display Aβ deposits and glial pathology while lacking Aβ dimers and other Alzheimer's pathologies.

Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer’s Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein

Synthetic amyloid-β oligomers drive early pathological progression of Alzheimer’s disease in nonhuman primates

Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease

Bridging the rodent to human translational gap: Marmosets as model systems for the study of Alzheimer's disease

Effect of hormone replacement therapy on amyloid beta (Aβ) plaque density in the rhesus macaque amygdala

Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathy

Model organism development and evaluation for late‐onset Alzheimer's disease: MODEL‐AD

Evaluating the brain renin‐angiotensin system (RAS) and sex differences in pre‐clinical models of Alzheimer’s Disease

A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis

Bearded capuchin monkeys as a model for Alzheimer's disease